(Press-News.org) Drinking coffee could decrease the risk of breast cancer recurring in patients taking the widely used drug Tamoxifen, a study at Lund University in Sweden has found. Patients who took the pill, along with two or more cups of coffee daily, reported less than half the rate of cancer recurrence, compared with their non-coffee drinking, Tamoxifen-taking counterparts.
The team followed over 600 breast cancer patients from southern Sweden for an average of five years. Approximately 300 took Tamoxifen. The drug, a common hormone therapy after breast cancer surgery, reduces the risk of new tumours by blocking oestrogen receptors. How coffee interacts with the treatment, however, isn't immediately known.
"One theory we are working with is that coffee 'activates' Tamoxifen and makes it more efficient", says Maria Simonsson, doctoral student in Oncology at Lund University.
The Lund University researchers have previously linked coffee consumption to a decreased risk of developing certain types of breast cancer. Caffeine has also been shown to hamper the growth of cancer cells. The latest observational study involving coffee's role in cancer prevention and treatment underlines the need for more research, according to the team.
"We would like to know more about how lifestyle can interact with breast cancer treatment", says Helena Jernström, Associate Professor of Experimental Oncology at Lund University.
### END
Coffee may help prevent breast cancer returning, study finds
2013-04-25
ELSE PRESS RELEASES FROM THIS DATE:
Study shows early dialogue between parents, children stems teen smoking
2013-04-25
Early, substantive dialogue between parents and their grade-school age children about the ills of tobacco and alcohol use can be more powerful in shaping teen behavior than advertising, marketing or peer pressure, a University of Texas at Arlington marketing researcher has shown.
The findings of Zhiyong Yang, an associate professor of marketing in the UT Arlington College of Business, are published in a recent edition of the Journal of Business Research. Similar findings were part of a 2010 study he published in the Journal of Public Policy & Marketing of the American ...
Europe needs genetically engineered crops, scientists say
2013-04-25
The European Union cannot meet its goals in agricultural policy without embracing genetically engineered crops (GMOs). That's the conclusion of scientists who write in Trends in Plant Science, a Cell Press publication, based on case studies showing that the EU is undermining its own competitiveness in the agricultural sector to its own detriment and that of its humanitarian activities in the developing world.
"Failing such a change, ultimately the EU will become almost entirely dependent on the outside world for food and feed and scientific progress, ironically because ...
As people live longer and reproduce less, natural selection keeps up
2013-04-25
In many places around the world, people are living longer and are having fewer children. But that's not all. A study of people living in rural Gambia, published in the Cell Press journal Current Biology on April 25, shows that this modern-day "demographic transition" may lead women to be taller and slimmer, too.
"This is a reminder that declines in mortality rates do not necessarily mean that evolution stops, but that it changes," says Ian Rickard of Durham University in the United Kingdom.
Rickard and Alexandre Courtiol of the Leibniz Institute for Zoo and Wildlife ...
New insights into Alzheimer's gene paves the way for prevention
2013-04-25
Alzheimer's disease is the most common neurodegenerative disorder, affecting more than five million Americans, but currently there is no way to prevent, delay or stop its progression. A study published online April 25 by the Cell Press journal Neuron shows that a gene called CD33 contributes to Alzheimer's disease by inhibiting the ability of immune cells to remove toxic molecules in the brain. The findings provide new insights into the molecular causes of the disease and reveal a novel potential therapy that could prevent cognitive decline and brain damage at early stages.
"Before ...
Gene networks in brains of deceased patients reveal potential therapy for Alzheimer's disease
2013-04-25
Most information about the cause of Alzheimer's disease is based on studies from animal models. Now, a study published by Cell Press on April 25th in the journal Cell examines the brain tissue of deceased human patients and sheds light on dysfunctions in molecular networks in the brain that are at the root of Alzheimer's disease. By showing that the TYROBP gene plays a key role in disrupting immune system pathways in the brains of Alzheimer's patients, the study reveals a potential therapeutic target for preventing brain damage caused by this debilitating disease.
"Our ...
Potential diabetes breakthrough
2013-04-25
Cambridge, MA, April 25, 2013 --- Researchers at the Harvard Stem Cell Institute (HSCI) have discovered a hormone that holds promise for a dramatically more effective treatment of type 2 diabetes, a metabolic illness afflicting an estimated 26 million Americans. The researchers believe that the hormone might also have a role in treating type 1, or juvenile, diabetes.
The work was published today by the journal Cell as an early on-line release. It is scheduled for the May 9 print edition of the journal.
The hormone, called betatrophin, causes mice to produce insulin-secreting ...
Scientists at Mount Sinai discover a key mechanism for a common form of Alzheimer's disease
2013-04-25
Scientists from the Icahn School of Medicine at Mount Sinai, in collaboration with researchers from Icelandic Heart Association, Sage Bionetworks, and other institutions, have discovered that a network of genes involved in the inflammatory response in the brain is a crucial mechanism driving Late Onset Alzheimer’s Disease (LOAD). The findings, published online today in the journal Cell, provide new understanding of key pathways and genes involved in LOAD and valuable insights to develop potential therapies for the disease.
To date, scientists have been challenged in ...
Entire galaxies feel the heat from newborn stars
2013-04-25
When galaxies form new stars, they sometimes do so in frantic episodes of activity known as starbursts. These events were commonplace in the early Universe, but are rarer in nearby galaxies.
During these bursts, hundreds of millions of stars are born, and their combined effect can drive a powerful wind that travels out of the galaxy. These winds were known to affect their host galaxy -- but this new research now shows that they have a significantly greater effect than previously thought.
An international team of astronomers observed 20 nearby galaxies, some of which ...
Alzheimer's risk gene presents potential treatment target
2013-04-25
Massachusetts General Hospital (MGH) investigators have determined that one of the recently identified genes contributing to the risk of late-onset Alzheimer's disease regulates the clearance of the toxic amyloid beta (A-beta) protein that accumulates in the brains of patients with the disease. In their report receiving advance online publication in Neuron, the researchers describe a protective variant of the CD33 gene that promotes clearance of A-beta from the brain. They also show that reducing expression of CD33 in immune cells called microglia enhances their ability ...
Suppressing protein may stem Alzheimer's disease process
2013-04-25
Scientists funded by the National Institutes of Health have discovered a potential strategy for developing treatments to stem the disease process in Alzheimer's disease. It's based on unclogging removal of toxic debris that accumulates in patients' brains, by blocking activity of a little-known regulator protein called CD33.
"Too much CD33 activity appears to promote late-onset Alzheimer's by preventing support cells from clearing out toxic plaques, key risk factors for the disease," explained Rudolph Tanzi, Ph.D., of Massachusetts General Hospital and Harvard University, ...